Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+16.79%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$205B
AUM Growth
+$205B
Cap. Flow
+$7.55B
Cap. Flow %
3.68%
Top 10 Hldgs %
37.27%
Holding
484
New
38
Increased
175
Reduced
104
Closed
12

Sector Composition

1 Consumer Discretionary 29.73%
2 Healthcare 22.49%
3 Technology 18.75%
4 Communication Services 13.22%
5 Financials 4.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TSCO icon
326
Tractor Supply
TSCO
$31.9B
$28K ﹤0.01%
+151
New +$28K
DBX icon
327
Dropbox
DBX
$7.82B
$27K ﹤0.01%
881
EBS icon
328
Emergent Biosolutions
EBS
$418M
$27K ﹤0.01%
423
GGG icon
329
Graco
GGG
$14B
$27K ﹤0.01%
+363
New +$27K
HUM icon
330
Humana
HUM
$37.5B
$26K ﹤0.01%
+58
New +$26K
NKTR icon
331
Nektar Therapeutics
NKTR
$543M
$26K ﹤0.01%
1,542
PD icon
332
PagerDuty
PD
$1.44B
$26K ﹤0.01%
615
NVRO
333
DELISTED
NEVRO CORP.
NVRO
$26K ﹤0.01%
154
SMAR
334
DELISTED
Smartsheet Inc.
SMAR
$26K ﹤0.01%
353
BOX icon
335
Box
BOX
$4.69B
$25K ﹤0.01%
979
CHRS icon
336
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$25K ﹤0.01%
1,807
TSP
337
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$25K ﹤0.01%
+349
New +$25K
PFPT
338
DELISTED
Proofpoint, Inc.
PFPT
$25K ﹤0.01%
144
-10
-6% -$1.74K
KEYS icon
339
Keysight
KEYS
$28.4B
$24K ﹤0.01%
158
-11
-7% -$1.67K
NTNX icon
340
Nutanix
NTNX
$18.2B
$24K ﹤0.01%
621
APTV icon
341
Aptiv
APTV
$17.3B
$23K ﹤0.01%
149
AVY icon
342
Avery Dennison
AVY
$13B
$23K ﹤0.01%
110
-8
-7% -$1.67K
PGNY icon
343
Progyny
PGNY
$2.02B
$23K ﹤0.01%
396
-40
-9% -$2.32K
MNTV
344
DELISTED
Momentive Global Inc. Common Stock
MNTV
$23K ﹤0.01%
1,095
ACMR icon
345
ACM Research
ACMR
$1.72B
$22K ﹤0.01%
220
CARG icon
346
CarGurus
CARG
$3.51B
$22K ﹤0.01%
860
+515
+149% +$13.2K
EXPO icon
347
Exponent
EXPO
$3.63B
$22K ﹤0.01%
242
INSM icon
348
Insmed
INSM
$30.3B
$22K ﹤0.01%
787
DGX icon
349
Quest Diagnostics
DGX
$20.1B
$21K ﹤0.01%
160
ROL icon
350
Rollins
ROL
$27.3B
$21K ﹤0.01%
605